New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
08:05 EDTINSMInsmed completes enrollment for Clear-108 Phase 3 study of Arikace
Insmed announced that the Company's CLinical Evaluation of Arikace phase 3 European and Canadian registrational study of Arikace for Cystic Fibrosis patients with Pseudomonas aeruginosa lung infections has now enrolled over 300 patients.
News For INSM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
18:51 EDTINSMOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTINSMInsmed files to sell 10M shares of common stock
Subscribe for More Information
March 24, 2015
13:54 EDTINSMInsmed personnel strong, says Piper Jaffray
After attending Insmed's analyst event, Piper says that the company has assembled a strong development and commercial team . The firm adds that the company has forged unique relationships with specialists and patients. It keeps an Overweight rating on the shares.
March 23, 2015
09:06 EDTINSMInsmed appoints Eugene Sullivan as Chief Medical and Scientific Officer
Subscribe for More Information
March 20, 2015
09:25 EDTINSMInsmed to host analyst and investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use